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Abstract Ras homolog enriched in brain (RHEB1) is a
member within the superfamily of GTP-binding proteins
encoded by the RAS oncogenes. RHEB1 is located at the
crossroad of several important pathways including the
insulin-signaling pathways and thus plays an important role
in different physiological processes. To understand better
the physiological relevance of RHEB1 protein, the expression pattern of RHEB1 was analyzed in both embryonic (at
E3.5–E16.5) and adult (1-month old) mice. RHEB1 immunostaining and X-gal staining were used for wild-type and
Rheb1 gene trap mutant mice, respectively. These independent methods revealed similar RHEB1 expression patterns during both embryonic and postnatal developments.
Ubiquitous uniform RHEB1/β-gal and/or RHEB1 expression was seen in preimplantation embryos at E3.5 and postimplantation embryos up to E12.5. Between stages E13.5
and E16.5, RHEB1 expression levels became complex: In
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particular, strong expression was identified in neural tissues, including the neuroepithelial layer of the mesencephalon, telencephalon, and neural tube of CNS and dorsal root
ganglia. In addition, strong expression was seen in certain
peripheral tissues including heart, intestine, muscle, and
urinary bladder. Postnatal mice have broad spatial RHEB1
expression in different regions of the cerebral cortex, subcortical regions (including hippocampus), olfactory bulb,
medulla oblongata, and cerebellum (particularly in Purkinje
cells). Significant RHEB1 expression was also viewed in
internal organs including the heart, intestine, urinary bladder, and muscle. Moreover, adult animals have complex tissue- and organ-specific RHEB1 expression patterns with
different intensities observed throughout postnatal development. Its expression level is in general comparable in CNS
and other organs of mouse. Thus, the expression pattern of
RHEB1 suggests that it likely plays a ubiquitous role in the
development of the early embryo with more tissue-specific
roles in later development.
Keywords Rheb1 gene · Expression pattern ·
Immunohistochemistry · X-gal staining · Gene trap ·
Embryos · Adult mice

Introduction
Ras homolog enriched in brain (RHEB1) is a GTPase that
is conserved from yeast to human. RHEB1 belongs to
a unique family within the Ras superfamily of GTPases
(Urano et al. 2000; Li et al. 2004). Rheb1 was initially
identified as a gene whose expression is rapidly induced
upon synaptic activity in the rat hippocampus (Yamagata
et al. 1994). Homologues of the Rheb gene have been
identified in a number of non-mammalian organisms and

mammals including mouse, rat (Yamagata et al. 1994), and
human (Gromov et al. 1995; Mizuki et al. 1996). Lower
eukaryotes such as yeast or Drosophila have only one gene,
whereas mammals have two different Rheb genes Rheb1
(originally abbreviated as Rheb) and Rheb2 (RhebL1)
(Patel et al. 2003); for review, see (Aspuria and Tamanoi
2004; Heard et al. 2014). Analysis of Rheb1 mRNA expression profiles showed that Rheb1 is ubiquitously expressed,
whereas Rheb2 expression is more restricted (Saito et al.
2005). Genetic studies in Drosophila place RHEB1 in the
insulin-signaling pathway, downstream of the tuberous
sclerosis complex (TSC1/TSC2) and upstream of mTOR/
S6K1 (Stocker et al. 2003). RHEB1 protein is a direct
target of the tuberous sclerosis complex (TSC1/2), and it
relays upstream signals to regulate mTORC1. TSC1/2
inhibits the mTOR/S6K/4EBP1 signaling pathway by
stimulating GTP hydrolysis of RHEB1 and its functions between TSC2 and mTOR (Manning and Cantley
2003). Inactivation of TSC1/2 leads to the activation of
the RHEB1/mTOR/S6K signaling cascade (Uhlmann et al.
2004). Although the molecular mechanism has not yet been
clearly defined, RHEB-GTP activates the target of rapamycin complex 1 (TORC1). TORC1 consists of multiple protein components, including the mammalian target of rapamycin (mTOR) itself and the regulatory-associated protein
of mTOR (Raptor), and is a major regulator of cell growth
that phosphorylates multiple downstream targets including
p70 S6 kinase (S6K) and the eukaryotic initiation factor 4E
(eIF4E)-binding proteins 1 and 2 (4E-BP1 and 4E-BP2).
RHEB1 activity can be blocked by rapamycin, an inhibitor of mTOR. As a member of TSC1/TSC2/RHEB1/mTOR
signaling pathway, RHEB1 participates in the regulation of
cell growth, aging, ribosome biogenesis, protein synthesis,
actin cytoskeletal organization, autophagy, and metabolism
(Heard et al. 2014). The importance of the Rheb1 gene in
tumorigenesis and other pathologies in patients and in
mouse has become appreciated in just the last several years.
In humans, inactivation of the TSC1–TSC2 complex leads
to inappropriate activation of RHEB1 and results in tuberous sclerosis (TS) disease (Tee et al. 2003a, b). TS is an
autosomal dominant hamartoma syndrome caused by mutations in tumor suppressor genes Tsc1/2. The hallmark of
TS is the development of a type of benign tumors called
hamartomas found in brain, kidney, lung, and other organs
of TSC patients (Mizuguchi and Takashima 2001).
Overexpression and/or amplification of Rheb1 was
detected in most breast, lung, prostate, skin, pancreatic,
and melanoma tumor cell lines (Lu et al. 2010; Basso
et al. 2005; Zheng et al. 2010). Also, overexpression and/
or mutations of Rheb1 were identified in tumors in different organs of patients including prostate (Chakraborty et al.
2008; Eom et al. 2008; Nardella et al. 2008), breast, head
and neck (Lu et al. 2010), uterus, and kidney (Lawrence

et al. 2014). Overexpression of RHEB1 in the tissues of
experimental mouse models also stimulates tumor growth.
For example, tissue-specific RHEB1 expression in basal
epidermal keratinocytes of K14-Rheb1 transgenic mice
leads to activation of the mTOR pathway and development
of skin tumors (Lu et al. 2010). Moreover, increased level
of RHEB1 can produce rapid development of aggressive
and drug-resistant lymphomas in experimental mouse models and is highly expressed in some human lymphomas,
resulting in activation of downstream mTOR signaling
(Mavrakis et al. 2008). Gene targeting of Rheb1 in mouse
leads to embryonic lethality of homozygote embryos
around mid-gestation (Goorden et al. 2011; Zou et al.
2011). Embryonic death most likely results from impaired
development of the cardiovascular system (Goorden et al.
2011; Tamai et al. 2013). Furthermore, Rheb1−/− mouse
embryonic fibroblasts (MEFs) are much smaller than control cells and are severely impaired in their ability to proliferate (Goorden et al. 2011). Conditional knockout of Rheb1
in neural progenitor cells demonstrated that embryonic
RHEB1 expression is essential for mTORC1 signaling and
myelination in the brain (Zou et al. 2011). Furthermore,
conditional Rheb1 targeting demonstrates that its expression is important for normal functions in T cells (Delgoffe
et al. 2011), B cells (Hamada et al. 2009), and male fertility
(Baker et al. 2014).
In summary, RHEB1 is important for the normal functions of a wide array of different cells. The study of its
expression in different tissues and organs will provide an
opportunity to better understand its role in normal development and perhaps help to discover novel functions and
features.
Initially, the expression of Rheb1 and Rheb2 genes in
human has been studied at the level of mRNA by Northern
blot analysis (Gromov et al. 1995) and (Saito et al. 2005),
respectively. In mouse, expression pattern of the genes
has been studied mostly at the level of mRNA by in situ
hybridization with particular focus on the central nervous
system (CNS) (Yamagata et al. 1994; Magdaleno et al.
2006), (Allen Developing Mouse Brain Atlas). It is known
that expression level of mRNA does not always reflect protein level (Kozak 2007). The discrepancy between mRNA
and protein levels can arise for a number of reasons, ranging from stage- or tissue-specific differences in the transcription, stability, or translation of mRNAs, to various
steps in translation, or even to posttranslational events
affecting protein stability and/or ubiquitination. With this
potential complexity in mind, we studied the expression
of the RHEB1 protein in wide spectrum of tissues during
embryonic and postnatal development in wild-type mice.
Moreover, to provide an independent approach to report
the expression pattern, we produced and used a mutant
Rheb1 gene trap (referred to below as Rheb1Δ/+) mouse.

The promoter trap modification of the gene trap method
is the tool to target genes that are active in ES cells (Friedrich and Soriano 1991; Skarnes et al. 1992; Wilson et al.
1995; Fedorov 2004). The promoterless pT1βgeo gene trap
vector (Wilson et al. 1995) containing a splice acceptor in
front of the β-gal reporter gene and expression of the β-gal
gene is controlled by the promoter of the “trapped gene.”
Hence, the endogenous promoter of the trapped gene drives
the expression of the reporter gene and thereby reflects the
expression pattern of trapped gene. Thousands of genes
(including Rheb1) were trapped in ES cells by EUCOMM
to generate mutant mice; for review, see (Friedel and Soriano 2010).

Determination of sequence of trapped gene
Rapid amplification of cDNA ends (RACE) method was
used by EUCOMM to reveal the fused transcript of the first
exon of the Rheb1 and βgeo cassette and was confirmed
by our laboratory. RNA was isolated from brain tissue of
1-month Rheb1Δ/+ mouse using TRIZOL Reagent (Invitrogen Life Technologies, cat #15596018) according to the
manufacturer’s instructions. RNA was reverse-transcribed
using QuantiTect Reverse Transcription Kit (QIAGEN,
cat #205311). The resulting cDNA was directly sequenced
with Rheb–βGalF primer (Supplementary Table S2).
Quantitative RT‑PCR

Materials and methods
Experimental animals
An ES clone harboring a gene trap vector pT1βgeo in
intron 1 of Rheb1 from EUCOMM was used to generate Rheb1Δ/+ mutant mice. These ES cells (129/Sv background) were injected into (B6D2F1)xB6 blastocysts as
described elsewhere (Fedorov et al. 1997). After germ line
transmission (GLT), the Rheb1 targeted allele was transferred into a C57Bl/6N background (Charles River Lab;
more than 10 backcrosses). Mutant mice were raised under
SPF conditions. All mouse experiments were performed in
accordance with the guidelines established by the Institutional Animal Care and Use Committees of Oregon Health
and Science University (Portland, OR, USA) and FriedrichSchiller-University (Jena, Germany).
PCR genotyping
Preparation of tissues from embryonic and adult mice and
PCR were done as previously described (Tian et al. 2011).
The presence of the pT1βgeo vector was identified with
primers corresponding to the β-galactosidase gene: forward primer 5′-GCG TTG GCA ATT TAA CCG CC-3′ and
reverse primer 5′-CAG TTT ACC CGC TCT GCT AC-3′.
The resulting PCR product was 450 b.p. To genotype
wild-type Rheb1 and Rheb1Δ allele, the additional pairs of
primers were used. The sense primer RhebF1235 5′-CCT
AGA CTG GAC CCC TCA CA-3′ and antisense primer
RhebR1620 5′-ACG TGA CAG TCC CCT GTT CC-3′
were used to amplify a 385-bp fragment of wild-type allele,
whereas a combination of the same sense RhebF1235
primer and mR4 5′-TGT GGG AAA GCC TTC AAA
GGG-3′ amplifies a 238-bp fragment of the Rheb1Δ allele.
PCR was performed using the following protocol: 95 °C for
5 min followed by 35 cycles: 45 s at 95 °C, 45 s at 58 °C,
and 1 min at 72 °C followed by 6-min extension at 72 °C.

RNA from the tissues of wild-type mice was prepared and
reverse-transcribed as described above and treated with
DNase. Equal amounts of input RNA were used for all
QRT-PCRs. QRT-PCR was performed using SYBR Green
I reagent. Primers for Ex1-Ex5 of Rheb1 (Supplementary Table S2) and transcript-specific primers for β-actin
as an endogenous control were used to evaluate the level
Rheb1 mRNA. The 2-ddCT relative quantification method
was used to calculate fold difference in transcript levels
between samples. Amplification efficiencies for the primer
pairs were verified to be equivalent over a range of template
concentrations. QRT-PCR was performed using an Applied
Biosystems 7300 Real-Time PCR thermocycler (Applied
Biosystems, Foster City, CA).
Embryo generation
Staged embryos were produced by mating between wild
type mice or between wild-type females and Rheb1 GT
males. The blastocysts were isolated at E3.5 from uterus,
and zona pellucida was removed by incubating with 0.5 %
pronase during 2-min incubation at RT. After they were
subjected for X-gal staining or for in vitro culture 3 days
with 5 % CO2 for 24 h at 37 °C in DMEM containing
15 % fetal bovine serum without leukemia inhibiting factor. The E9.5–E16.5 embryos were removed from uteri and
dissected free of extraembryonic membranes in ice-cold
phosphate-buffered saline (PBS) and stained with X-gal
(below). Embryo staging and organ identification were performed according to Kaufman (1995).
X‑gal staining
Whole-mount specimens and cryostat-sectioned tissue samples were stained as previously described (Fedorov et al.
2001). For whole-mount X-gal staining, Rheb1Δ/+ and
wild-type embryos at E9.5–E13.5 were fixed for 15–90 min
(depending on embryonic stage) in 4 % paraformaldehyde

at 4 °C. After fixation, embryos were washed three times
for 5 min in PBS at RT and stained at 37 °C for 3–12 h
(depending on stage) in a solution containing 0.04 % X-gal,
0.01 % sodium deoxycholate, 0.02 % Nonidet P-40, 5 mM
K3Fe(CN)6, and 5 mM K4Fe(CN)6. After staining, the specimens were embedded in paraffin, and 10-μm sections were
cut and mounted with coverslips. For X-gal staining, E16.5
embryos and tissue samples from adult Rheb1Δ/+ mice
were rinsed in PBS and freeze-mounted in OCT medium
(Sakura, Japan). Frozen 25-μm sections were cut on a cryostat and mounted on Super Frost Plus slides. Slides were
stained with X-gal solution, counterstained with eosin, and
mounted with coverslips.
Immunohistochemistry
Staged wild-type embryos were fixed overnight in Bouin’s
solution (4 % paraformaldehyde, 0.15 % picric acid,
pH 7.4) at 4 °C followed by paraffin embedding and cut
on a microtome 10-μm sections. The sections were then
blocked for endogenous peroxidase activity using 3 %
hydrogen peroxide for 10 min prior to staining. Adult mice
were anesthetized and transcardially perfused with physiological saline (0.9 % NaCl + heparin) followed by fixation
in Bouin’s solution. The brain was then dissected, placed
in fixative for 1 h at RT, and subsequently transferred to
20 % sucrose in PBS for 24 h at 4 °C and freeze-mounted
in OCT medium (Sakura, Japan). The frozen brain was
sectioned on a cryostat, and 25-μm sections were blocked
for endogenous peroxidase activity using 0.3 % hydrogen
peroxide in methanol for 30 min prior to staining. The
sections of embryonic and adult tissues were blocked for
1 h in 5 % normal goat serum (NGS) in TBST at RT and
then were incubated overnight in rabbit polyclonal antiRHEB1 primary antibody (dilution 1:400; Cell Signaling,
# 4935) at 4 °C. Paraffin-embedded 10-µm-thick sections
of the internal organs were deparaffined, rehydrated, and
microwaved 6 min in 10 mM sodium citrate buffer pH 5.5.
Subsequently, the slides were incubated 6 min in peroxidase blocking solution (3 % H2O2 in PBS). After antigen
retrieval, slides were rinsed in PBS, incubated in 20 %
sucrose in PBS at +4 °C for 30 min, washed in PBS, and
placed in blocking buffer (2.5 % goat serum in PBS), and
then were incubated overnight in rabbit polyclonal antiRHEB primary antibody (dilution 1:400; Cell Signaling,
# 4935) at 4 °C. After incubation with primary antibody,
the sections were incubated in biotinylated goat anti-rabbit
secondary antibody (dilution 1:500) (Molecular Probes,
OR, USA, cat # R-21459) for 30 min at RT in 1.5 % NGS
in TBST. Antigen–antibody complexes were detected with
the immunoperoxidase system (Vectastain Elite ABC Kit,
# PK-6101, Vector Laboratories, Inc). Sections were then

counterstained using Mayer’s hematoxylin, mounted on
slides, and imaged under a Leica DM2000 microscope
using LAS V3.7 software. For fluorescent immunohistochemistry, the brains were isolated from the wild-type
embryos at E15.5 and placed into 4 % paraformaldehyde
made in PBS overnight at 4 °C. Brains were then embedded
in 2 % agarose, and 50-μm vibratome sections were collected and used for immunofluorescence staining. Before
staining, the sections were blocked for 1 h in 0.1 % cold
water fish-skin gelatin/1 % BSA/0.5 % TritonX-100/0.1 M
Tris-buffered saline (all from Sigma). After blocking, primary antibodies were added (RHEB1, 1:400; Cell Signaling and Nestin, 1:1000; BD Biosciences) overnight at 4 °C
on a rotating shaker and then washed 3× in 10 min each
wash in 1× PBS. Alexa Fluor fluorescent secondary antibodies (Life Technologies # R37117) were applied to the
sections at 1:1000 in the same blocking solution as listed
above with 5 % NGS. Sections were place on a rotating
shaker for 1 h protected from light before being washed
again 3× in 1× PBS as described above. Sections were
then mounted on slides and imaged using a Nikon confocal
microscope. Identification of tissues of brain and internal
organs of adult mice was performed using Atlas of mouse
brain (Paxinos 2008) and histological Atlas of mouse tissues (ACVP 2012).

Results
Identification of gene trap vector integration site
The promoterless pT1βgeo gene trap vector containing a
splice acceptor in front of the β-gal reporter gene was used
to target the Rheb1 locus (Fig. 1a, b). The precise integration site of the vector into intron 1 of Rheb1 was identified using PCR and sequencing analysis. Fifteen forward
primers (F24–F38) were designed to cover the sequence
of intron 1 of Rheb1 (Fig. 1c; Supplementary Table S1).
DNA of ES clone was subjected to PCR using the forward
primers in combination with reverse primer R4 corresponding to En-2 intron region of pT1βgeo. PCR with primers
F24 and R4 resulted in PCR product of 650 bp. Sequencing of this fragment confirmed the vector integrated 610 bp
downstream of exon 1. The integration site is located at
NCBIM37:5:24309691 and NCBIM37:5:24309815 of
the mouse genome. Based on these results, the new pair
of primers was designed and used for PCR genotyping of
Rheb1Δ/+ mice in addition to pair of LacZ primers (Fig. 1f,
Table S1). Fusion of the first exon of Rheb1 with the βgeo
cassette was originally identified by EUCOMM and confirmed in our laboratory (Fig. 1d, e; Supplementary Table
S1).

Fig. 1 Gene trap strategy
used to disrupt Rheb1 locus.
a pT1βgeo gene trap vector
does not contain a promoter
but contains a splice acceptor
in front of the β-geo cassette.
b Exon–intron structure of
wild-type Rheb1. c Scheme of
identification of integration site
of pT1βgeo into intron 1 using a
set of forward primers F24–F38
and reverse primer R4. d Partial
sequence of rapid amplification of cDNA ends (RACE)
product (5′ → 3′ orientation)
of Rheb1 gene trap ES clone
after integration of pT1βgeo.
Sequence of exon 1 is shown in
bold italic font, whereas β-gal is
shown in regular font. e Scheme
of mRNA transcript of trapped
allele of Rheb1. f PCR genotyping of founders harboring
gene trap vector. PCR product
(238 bp) of trapped allele is
indicated by Δ

RHEB expression in mouse embryos
Both X-gal histochemistry and RHEB1 immunohistochemistry (IHC) stainings were used to describe RHEB1
expression pattern in mouse embryos beginning from
embryonic day 3.5 (E3.5) through E16.5. After integration of the pT1βgeo vector, the β-gal reporter gene is controlled by the promoter of Rheb1 and thereby reflects the
pattern of expression of the trapped Rheb1 locus. Initially,
β-gal expression was tested in ES cells, and positive X-gal
staining was identified (Fig. 2a). Subsequently, activity was
tested on embryos of different developmental stages after
mating of wild-type females with Rheb1Δ/+ males. Eight of
seventeen E3.5 embryos were X-gal positive, whereas all
14 wild-type embryos (after breeding wild-type female and
male) were negative (Fig. 2b). We did not perform PCR
genotyping of embryos at this stage, but the 47 % of β-gal
positive embryos closely reflects the expected 50 % Mendelian distribution, confirming that green–blue embryos were
indeed Rheb1Δ/+ mutants. Similar results were produced in
embryos at E6.5 cultured in vitro: 3/7- and 0/6 X-gal-positive embryos from wild-type mutant and wild-type crosses,
respectively (Fig. 2c, d). Later, the coincidence of positive
X-gal staining (Figs. 2e–h, 3) with genotype and Mendelian distribution of Rheb1Δ/+ embryos was confirmed by
their PCR genotyping at E9.5, E12.5, and E16.5. Wholemount staining of embryos at E9.5 and E12.5 revealed a

ubiquitous expression pattern (Fig. 2e–h) that is confirmed
on histological sections (Fig. 2i, j). Thus, X-gal staining
showed the uniform ubiquitous RHEB1 expression pattern
on the studied stages (E3.5–E12.5 embryos). We noted a
particularly intense expression of RHEB1 in the developing
CNS, specifically in the neuroepithelial layer of the midbrain, forebrain and neural tube, and dorsal root ganglia.
To gain data about Rheb1 expression on the second half of
gestation, the study was extended on histological sections
of E13.5 wild-type embryos by immunohistochemistry
(IHC) with an anti-RHEB1 antibody. In spite of early-stage
embryos showing uniform ubiquitous RHEB1 expression
in CNS and other organs (Fig. 2b–i), the expression in the
embryos in the second half of gestation became more complex. Thus, the E13.5 embryos have still ubiquitous expression; however, the intensity of staining varied in different
tissues (Fig. 2k). Differential expression is more visible on
E16.5 Rheb1Δ/+ embryos after X-gal staining. (Figure 3a;
Supplementary Fig. S1b).The Rheb1Δ/+ embryos at E16.5
also revealed RHEB1/β-gal expression in different regions
of brain. A significant level of expression was found in
cerebral hemispheres, lens of the eye, spinal cord, and
spinal ganglia (Fig. 3a). If intensity of staining of different parts of CNS looks similar, then the intensity of staining of other organs varied among them. The greatest level
of expression was found in heart (Fig. 3a, b), all regions
of intestine (Fig. 3a, d), and urinary bladder (Fig. 3a, c).

Fig. 2 Detection of RHEB1 expression in wild-type and Rheb1Δ/+
mouse embryos at E3.5–E13.5. a Colonies of Rheb1Δ/+ ES cells
expressing β-gal on the wild-type MEF. b wild-type (top) and
Rheb1Δ/+ embryos (bottom) at E3.5 (blastocysts);. Red arrow shows
expressing β-gal (green) in the inner cell mass (ICM). c, d In vitro
cultured E6.5 wild-type and Rheb1Δ/+ embryos, respectively. β-gal
activity is greater in the ICM (yellow arrows) of Rheb1Δ/+ embryo,
than in surrounding trophoblast giant cells. β-gal activity is not found
in wild-type embryo (d). e, f Lateral view of Rheb1Δ/+ and wildtype embryo at E9.5, respectively; X-gal staining. g, h Lateral view

of Rheb1Δ/+ and wild-type embryos at E12.5, respectively; X-gal
staining. i Sagittal section of Rheb1Δ/+ embryo at E9.5. Ubiquitous
expression (light blue) of β-gal including the neuroepithelial layer of
midbrain, forebrain, and neural tube (red, yellow, and blue arrows,
respectively). j Sagittal section of wild-type embryo at E9.5; hematoxylin–eosin staining. k Immunohistochemical detection of RHEB1
expression in wild-type E13.5 embryo (sagittal section); blue and red
arrows point lung and liver, respectively. Immunoperoxidase (brown)
staining with hematoxylin counterstaining (blue). l The same embryo
stained with hematoxylin–eosin

Moderate expression was also observed in stomach, esophagus, kidney (Fig. S1a, b, c), skeletal muscle, follicles of
vibrissae, glans penis (Fig. 3a), with low expression in
liver, adrenal gland (Supplementary Fig. S1a, b), pancreas,
and testes (not shown). Faint RHEB1/β-gal expression) was
detected in lung and liver of Rheb1Δ/+ embryos at E16.5
(light blue hue against the pink eosin background; Fig. 3a,
Supplementary Fig. S1a, b), whereas it is visible well in
wild-type embryos at E13.5 after IHC (Fig. 2k). In contrast
to Rheb1Δ/+ embryos, no β-gal expression was identified
in wild-type embryos at any tested stage including E16.5

(Fig. 3e and data not shown). In summary, both X-gal staining and IHC methods showed that RHEB1 protein expression changes with embryonic age from ubiquitous to differential expression patterns throughout development.
To test a possible participation of RHEB1 in regulation
of CNS development, we conducted fluorescent immunostaining of the brain of wild-type embryo at E15.5 using
anti-RHEB and anti-Nestin antibody. Nestin is an intermediate filament protein selectively expressed in neuronal
stem cells (Sunabori et al. 2008). Fluorescent IHC showed
co-localization of both proteins in the neuroepithelial layer

Fig. 3 Identification of
RHEB1/β-gal in tissues of
Rheb1Δ/+ embryos at E16.5
after X-gal staining (blue) counterstained with eosin (red). a
Sagittal cryosection, RHEB1/βgal expression in cerebral
hemisphere (CH), lens of eye
(L), lung (Lg), liver (Lv), spinal
cord (SC), heart (H), intestine
(I), urinary bladder (UB). b
Expression in myocardial cells
of right ventricle (cross-sectioned myofibers), c in smooth
muscle wall of urinary bladder.
d Epithelial layer of duodenum.
e Abdominal cavity of wild-type
embryo at E16.5 after X-gal
staining; sagittal cryosection

of embryonic brain, with projections into the cortex (Supplementary Fig. S2). RHEB1 expression in neuronal stem
cells strongly supports suggestion about its participation in
regulation of development of CNS.
RHEB1 expression in the brain of adult mice
To describe RHEB1 expression in postnatal wild-type and
Rheb1Δ/+mice, both IHC and X-gal stainings were used,
respectively. Analysis of the brain of 1-month-old wild-type
mice by IHC showed widespread expression of RHEB1 on
different cortical regions of brain including, frontal cortex,
motor cortex, piriform cortex, and somatosensory cortex
(Fig. 4a, b, d, e). Similar expression patterns were visible
in the brain of Rheb1Δ/+ mice after X-gal staining (Fig. 4c,
f). Widespread expression was also identified in different
subcortical brain structures, including different nuclei of
the thalamus (Fig. 5a, b, e, f), hypothalamus, pons, medulla

oblongata, and other regions (data not shown). Strong
expression was also identified in hippocampal CA fields
(Fig. 5a, b, f). Robust expression was also identified in cerebellum, particularly in Purkinje cells and the cells of granular layers that become easily visible after IHC (Fig. 5c,
g) and X-gal staining (Fig. 5d, h). Because of their large
size, the Purkinje cells of cerebellum were very useful to
observe the intracellular localization of RHEB1 protein.
Cytoplasmic and nuclear localization of RHEB1 is visible
after IHC as well as X-gal staining (Fig. 5g, h). Hence, we
show that Rheb1 is widely expressed in cerebral cortex and
different subcortical structures of adult brain.
RHEB1 expression in other organs of adult mice
In addition to the analysis of the RHEB1 expression in the
brain, its expression in several other organs was examined. Because of their robust staining during embryonic

Fig. 4 Detection of RHEB1 expression in the cortex of brain of 1month-old wild-type and Rheb1Δ/+ mice; sagittal sections. a, b, d, e
RHEB1 expression on different cortical regions of wild-type brain.

c, f RHEB1/β-gal expression in the brain of Rheb1Δ/+ mouse. Frontal
cortex (FC), motor cortex (MC), piriform cortex (PC), somatosensory
cortex (SSC)

Fig. 5 Detection of RHEB1 expression in the different regions of the
brain of 1-month-old wild-type and Rheb1Δ/+ mice. a, b, e, f RHEB1
expression in different regions on sagittal section of wild-type brain:
dentate gyrus (DG), dorsal lateral geniculate nucleus (DLG) of the
thalamus, hippocampus (H). c, g and d, h RHEB1 expression in cer-

ebellum, of wild-type and Rheb1Δ/+ mice, respectively; simple lobule
(SL) and ansiform lobule (AF) of cerebellum. g, h Strong expression of RHEB1 or RHEB1/β-gal in the nuclei of Purkinje cells (black
arrows) and in the cells of the granular layer (red arrows) is observed

development (Fig. 3), we analyzed RHEB1 expression in
heart, intestine, urinary bladder, and muscle of adult animals.
As shown in Fig. 6a–h, RHEB1 expression remains as intense

as in the E16.5 embryo. To compare approximately the level
of Rheb1 transcription in CNS and different organs of adult
mice, the level of Rheb1 mRNA was evaluated by QRT-PCR

Fig. 6 Immunohistochemical
detection of RHEB1 expression on cryosections of the
tissues of 4-week-old wild-type
and Rheb1Δ/+ mice. a RHEB1
expression in longitudinally oriented cardiomyofibers of heart,
c in the myocytes of striated
muscle, e in epithelium cells
of villi of ileum (intestine). b,
d, f Corresponding no primary
antibody control. Immunoperoxidase (brown) staining; in
addition, sections were counterstained with hematoxylin (blue).
g, h RHEB1/β-gal expression in
smooth muscle of urinary bladder of Rheb1Δ/+ mouse after
X-gal staining

in several regions of brain and internal organs (kidney and
heart) of WT mouse (Fig. S3). Similar high expression was
identified in temporal cortex of the brain and heart, whereas
other tissue/organs have twofold to threefold less expression.
Thus, adult animals have broad spatial expression patterns
with different intensity throughout postnatal development.

Discussion
In prior work, the systematic analysis of Rheb1 expression
was performed in mice at age E9.5 to postnatal day 56 (p.

56), specifically focusing on the level of mRNA in the CNS
(Allen Developing Mouse Brain Atlas) and (Magdaleno
et al. 2006). In the present study, we examined the expression of RHEB1 protein in a wide spectrum of mouse tissues
from both preimplantation (E3.5) and postimplantation
embryonic stages as well as from adult mice. Moreover,
we used wild-type and Rheb1Δ/+ mice that allowed us to
use two independent methods for assessing RHEB1 expression. In general, RHEB1 IHC and X-gal staining demonstrated similar expression patterns during both embryonic and postnatal development. We found that RHEB1 is
actively expressed in preimplantation embryos at E3.5 and

perhaps earlier. It seems that although RHEB1 is actively
expressed in preimplantation stages, its deficiency does not
affect preimplantation development but is critical soon after
implantation in the period of organogenesis, and Rheb1
−/−
embryos die on mid-gestation (Goorden et al. 2011;
Zou et al. 2011). Moreover, we observed that embryos
at the age E3.5–E12.5 have uniform ubiquitous RHEB1
expression, whereas in E13.5 and E16.5 embryos and later
in adult mice, the expression shifts from uniform ubiquitous to a more complex, tissue-specific pattern. Different
level of expression is more prominent on the section of
Rheb1Δ/+ E16.5 embryos (Fig. 3; Supplementary Fig. S1).
Although IHC and X-gal staining showed similar expression patterns for wild-type RHEB1 and targeted RHEB1/βgal proteins, there were staining differences among some
organs like in embryonic lung and liver at E13.5 and E16.5.
Our gene trap vector pT1βgeo contains neo gene, and its
expression might slightly reduce RHEB1/β-gal expression
in these organs. Based on these observations, we cannot
conclude that RHEB1 expression disappeared completely
in some organs/tissues. More likely, it is gradual reduction
in the expression in some tissues during embryonic development after E12.5, and therefore, in some cases, we cannot see low level of expression on histological section at
later stages. To conclude complete absence of expression
would require laser capture of individual cells with quantification via QRT-PCR.
RHEB1 protein expression pattern in the brain of wildtype and Rheb1Δ/+ embryos and adult mice was similar to
Rheb1 mRNA expression pattern of wild type published
previously (Allen Developing Mouse Brain Atlas) and
(Magdaleno et al. 2006). Interestingly, we identified the
high level of RHEB1 protein not only in different regions
of the brain but also in several internal organs such as heart,
intestine, and urinary bladder of embryos and adult animals. The comparison of RHEB1 expression levels in internal organs versus brain by QRT-PCR showed that the levels
are comparable in general. The strong RHEB1 synthesis in
the internal organs might also infer the functional significance of RHEB1 in these organs, and abnormalities in the
regulation of RHEB1 in these tissues can initiate pathological changes including cancer.
The goal of our study was to analyze the overall expression pattern of RHEB1 protein in different tissues of
mouse. Although our primary goal was not to focus on the
details of intracellular localization of RHEB1, we nevertheless observed RHEB1 localization in some cells. The
localization RHEB1 in cytoplasm is visible in the cells of
brain and internal organs of wild-type mice after IHC as
well as in the cells of Rheb1Δ/+ mice after X-gal staining.
Analysis of nuclear staining is more complicated. In most
tissues, it is difficult to conclude that we detected RHEB1
nuclear localization in general even though it looks like

nuclear staining. Some cells are small like the cells of the
cerebellar molecular layer. In other cases, it is not possible
to discriminate details of X-gal staining between subcellular nuclear compartments or perinuclear regions such as the
Golgi apparatus or endoplasmic reticulum. The question
will be answered after immunofluorescent staining via confocal microscopy in future studies. However, Purkinje cells
of the cerebellum are sufficiently large to permit detection
of the intracellular localization of RHEB1 protein. In these
cells, the cytoplasmic and nuclear localization of RHEB1 is
clearly visible after IHC as well as X-gal staining. To perform intracellular signaling from plasma membrane inside
cells, the proteins of Ras family have a C-terminal CAAX
(C = cysteine, A = aliphatic, X = terminal amino acid)
motif which is responsible for the association with plasma
and endo membranes; for review, see (Schmick et al. 2015).
In contrast to other proteins of RAS superfamily, endogenous RHEB1 has an atypical CAAX motif (CSVM) (Aspuria and Tamanoi 2004). The identification of RHEB1 in
cell compartments demonstrated in general localization to
the Golgi apparatus, endoplasmic reticulum (Buerger et al.
2006; Jiang and Vogt 2008; Hanker et al. 2010), vesicular
structures (Saito et al. 2005; Buerger et al. 2006; Sancak
et al. 2008), and mitochondria (Ma et al. 2008). Our surprising observation of RHEB1 localization in the nuclei of
the Purkinje cells of cerebellum is supported by fact that
other members of TSC1/2/RHEB1/mTOR signaling pathway including tuberin, an upstream regulator of RHEB1
and mTOR target of RHEB1, are also localized in the cytoplasm and nucleus of cells (Rosner et al. 2007). Moreover,
by using multiphoton microscopy, EGFP-RHEB1 localization was recently detected in both cytoplasmic and nuclear
regions in living HEK293, HeLa, and SHO transiently
transfected cells (Yadav et al. 2013). The level of RHEB1
expression was evaluated as ~40 % within the cell nucleus
and ~60 % within the cytoplasm, the Golgi apparatus, and
ER together.
We identified nuclear localization of RHEB1 in Purkinje
cells by both IHC and X-gal staining.
To enter into the nucleus, the nuclear proteins penetrate
the nuclear membrane through the nuclear pore complex
(NPC) (Davis 1995) or through nuclear import pathways
(Sorokin et al. 2007). Nuclear import depends on interaction between the nuclear localization signal (NLS) of
nuclear protein and its import receptor. NLS is a polybasic sequence comprised of multiple lysines (K) or arginines
(R). Lin et al. (2014) showed that template PxxK[KR]
x[KR]xx (a very common NLS motif) may have many
modifications and depended on binding affinity to its
import receptor, and it can potentially have different nuclear
import activity. Exon 1 of Rheb1 presents in both wild-type
Rheb1 and mutant Rheb1/β-gal gene of our experimental
mice. After translation of Exon 1, the N-terminus of both

proteins (wild-type RHEB1 and targeted RHEB1/β-gal)
contain PQSKSRK amino acid sequence that is similar to
PxxK[KR]x[KR]. We suggest that PQSKSRK motif functions as a NLS to import RHEB1 into nuclei. The role and
precise localization of RHEB1 within the cell nucleus is
unclear and must be studied in more detail in the future.
Finally, we extended here our knowledge about RHEB1
expression on the protein level during embryogenesis and
postnatal development in the CNS and several internal
organs. Our studies will thus contribute to further elucidating the function of RHEB1 in its normal biological context
as well as its role in the pathogenesis of different diseases.
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